Results
|
361.
|
|
|
362.
|
Comparison of effectiveness and safety of three different antithrombotic regimens (bivalirudin, eptifibatide, and heparin) in preventing myocardial ischemia during percutaneous coronary intervention. [electronic resource] by
- Wolfram, Roswitha
- Leborgne, Laurent
- Cheneau, Edouard
- Pinnow, Ellen E
- Canos, Daniel A
- Hellinga, David
- Satler, Lowell F
- Pichard, Augusto D
- Kent, Kenneth M
- Waksman, Ron
Producer: 20031202
In:
The American journal of cardiology vol. 92
Availability: No items available.
|
|
363.
|
|
|
364.
|
|
|
365.
|
|
|
366.
|
|
|
367.
|
|
|
368.
|
|
|
369.
|
|
|
370.
|
|
|
371.
|
|
|
372.
|
|
|
373.
|
Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non-ST-segment elevation acute coronary syndromes patients: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome trial. [electronic resource] by
- Bagai, Akshay
- White, Jennifer A
- Lokhnygina, Yuliya
- Giugliano, Robert P
- Van de Werf, Frans
- Montalescot, Gilles
- Armstrong, Paul W
- Tricoci, Pierluigi
- Gibson, C Michael
- Califf, Robert M
- Harrington, Robert A
- Newby, L Kristin
Producer: 20131211
In:
American heart journal vol. 166
Availability: No items available.
|
|
374.
|
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II. [electronic resource] by
- Tardiff, B E
- Califf, R M
- Tcheng, J E
- Lincoff, A M
- Sigmon, K N
- Harrington, R A
- Mahaffey, K W
- Ohman, E M
- Teirstein, P S
- Blankenship, J C
- Kitt, M M
- Topol, E J
Producer: 19990217
In:
Journal of the American College of Cardiology vol. 33
Availability: No items available.
|
|
375.
|
|
|
376.
|
|
|
377.
|
|
|
378.
|
|
|
379.
|
|
|
380.
|
|